Shelter Pharma Ltd
₹46.02▲ +0.11 (+0.24%)
SHELTER·BSE·Construction
Market Cap
79.32 Cr
PE Ratio
383.50
Volume
36,000
Day High - Low
48.20 - 46.02
52W High-Low
55.88 - 23.00
₹46.02▲ +0.11 (+0.24%)
Market Cap79.32 Cr
PE Ratio383.50
Volume36,000
Day High - Low48.20 - 46.02
52W High-Low55.88 - 23.00
Shelter Pharma Ltd (SHELTER): company summary
The company's business has improved significantly, with annual revenue rising 44.4% and annual net profit growing 24.7%.
Shelter Pharma Ltd (SHELTER) is a micro-cap Construction company valued at ₹79 crore operating in Civil Construction on the NSE and BSE.
- Recent price move
- Shelter Pharma Ltd last traded at ₹46.02, modestly up 0.24% on the day.
- Recent developments
- 2026-09-30: Promoter holding fell by 10.90 percentage points to 44.60%, indicating a significant reduction in promoter stake. 2026-06-30: The company reported a net loss of ₹0 crore for the latest quarter, contrasting with a net profit of ₹0 crore in the same quarter a year earlier.
- Financial performance
- The company's business has improved significantly, with annual revenue rising 44.4% and annual net profit growing 24.7%. However, the latest quarter shows a reversal, with net profit turning from a profit of ₹0 crore to a loss of ₹0 crore, while revenue remained flat compared to the same quarter a year earlier.
- Valuation multiples
- The stock trades at 383.5 times earnings, 1.42 times book value.
- Things to watch
- The company's net profit margin has narrowed by 1.9 percentage points to 12.3%, which may signal pressure on profitability. The latest quarter's net profit turned to a loss, raising concerns about short-term performance. The stock is 17.8% below its 52-week high, indicating a potential loss of value.
- Where it stands
- Shelter Pharma Ltd has shown strong growth in annual revenue and net profit over the past five years, but the latest quarter's performance has shifted to a net loss. The most significant movement is the drop in promoter holding, which now stands at 44.60%.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
5.1/10
Weak
Fair Value
Sign in to see
ROE
11.78%
Average
P/E
383.50x
Expensive
Debt / Equity
0.01
Low
Industry
Construction
Civil Construction
Overall View
Mixed
Price performance
Day₹46.02
₹48.20
52W₹23.00
₹55.88
DocStoX take
Supported by momentum (7.5) and growth (7.0), but held back by valuation (2.5). Momentum looks strong at 7.5, but that is offset by valuation at 2.5. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence5.1
/10
Weak
Quality
Modest
ROE 11.8%
Valuation
Expensive
P/E 200.0×
Growth
Steady
Revenue +90.3% 5Y CAGR
Risk
Moderate
D/E 0.01
Momentum
Strong
70% of 52-week range
At a glance
Market Cap
₹79 Cr
52W High / Low
₹56 / ₹23
Dividend Yield
0.00%
Promoter Holding
44.60%
EPS (TTM)
₹0.12
Book Value
₹46.13
Key highlights
- Revenue compounding 90% a year
- Profit compounding 59% a year
- Low leverage — D/E 0.01
- Loss-making in some of the last 5 years
- Expensive at 200× earnings
3 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Construction stocks · Civil Construction
Explore Shelter Pharma Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Shelter Pharma Ltd peers in Construction
Other Construction stocks on the NSE & BSE. See the full Construction sector list.
Related tools & concepts
Value Shelter Pharma Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing